Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | # Peptides (by Search Engine): A2 Sequest HT (Testis IgG) | # Peptides (by Search Engine): B2 Sequest HT (Testis SPKO) | # Peptides (by Search Engine): C2 Sequest HT (Testis HET) | # Peptides (by Search Engine): D2 Sequest HT (Testis WT) | # PSMs (by Search Engine): A2 Sequest HT (Testis IgG) | # PSMs (by Search Engine): B2 Sequest HT (Testis SPKO) | # PSMs (by Search Engine): C2 Sequest HT (Testis HET) | # PSMs (by Search Engine): D2 Sequest HT (Testis WT) | Abundance: F1: Sample, Testis IgG | Abundance: F2: Sample, Testis SPKO | Abundance: F3: Sample, Testis HET | Abundance: F4: Sample, Testis WT | Abundances Count: F1: Sample, Testis IgG | Abundances Count: F2: Sample, Testis SPKO | Abundances Count: F3: Sample, Testis HET | Abundances Count: F4: Sample, Testis WT | Modifications | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Ensembl Gene ID | Gene Symbol | Chromosome | Reactome Pathways | KEGG Pathways | # Razor Peptides |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High | P01027 | Complement C3 OS=Mus musculus OX=10090 GN=C3 PE=1 SV=3 | 0 | 3.068 | 1 | 2 | 3 | 2 | 1663 | 186.4 | 6.73 | 2 | 1 | 2 | 1 | 438539.6719 | 1461011.438 | 1132320.938 | 1111866.875 | 2 | 2 | 2 | 1 | cell organization and biogenesis;coagulation;defense response;metabolic process;regulation of biological process;response to stimulus | extracellular | enzyme regulator activity;protein binding | "Pf00207, Pf01759, Pf01821, Pf01835, Pf07677, Pf07678, Pf07703, Pf10569, Pf11974" | 12266 | ENSMUSG00000024164.15 | C3 | 17 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Regulation of Complement cascade; Peptide ligand-binding receptors; G alpha (i) signalling events; Activation of C3 and C5; Post-translational protein phosphorylation; Alternative complement activation; Neutrophil degranulation; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | Legionellosis; Staphylococcus aureus infection; Leishmaniasis; Complement and coagulation cascades; Herpes simplex infection; Tuberculosis; Viral carcinogenesis; Chagas disease (American trypanosomiasis); Systemic lupus erythematosus; Pertussis; Phagosome | 0 |